DaxibotulinumtoxinA for Injection for the Treatment of Glabellar Lines: Efficacy Results From SAKURA 3, a Large, Open-Label, Phase 3 Safety Study.

Authors

Sabrina G Fabi
Joel L Cohen
Lawrence J. Green, George Washington University
Sunil Dhawan
Theda C Kontis
Leslie Baumann
Todd M Gross
Conor J Gallagher
Jessica Brown
Roman G Rubio

Document Type

Journal Article

Publication Date

8-6-2020

Journal

Dermatologic Surgery

DOI

10.1097/DSS.0000000000002531

Comments

Online ahead of print

APA Citation

Fabi, S., Cohen, J., Green, L. J., Dhawan, S., Kontis, T., Baumann, L., Gross, T., Gallagher, C., Brown, J., & Rubio, R. (2020). DaxibotulinumtoxinA for Injection for the Treatment of Glabellar Lines: Efficacy Results From SAKURA 3, a Large, Open-Label, Phase 3 Safety Study.. Dermatologic Surgery, (). http://dx.doi.org/10.1097/DSS.0000000000002531

Peer Reviewed

1